TrianglePUBLICATIONS · 23265714
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2013 Apr
- First author
- Eckert C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Eckert C
- type
- Author
- name
- von Stackelberg A
- type
- Author
- name
- Seeger K
- type
- Author
- name
- Groeneveld TW
- type
- Author
- name
- Peters C
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Borkhardt A
- type
- Author
- name
- Schrappe M
- type
- Author
- name
- Escherich G
- type
- Author
- name
- Henze G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Eckert C
- type
- Author
- name
- von Stackelberg A
- type
- Author
- name
- Seeger K
- type
- Author
- name
- Groeneveld TW
- type
- Author
- name
- Peters C
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Borkhardt A
- type
- Author
- name
- Schrappe M
- type
- Author
- name
- Escherich G
- type
- Author
- name
- Henze G
- type
- Author
- bibliography ids
- nci-bib-543db4ba91e01a6998237d31
- book metadata
- content sha256
- 1115fc3d454e973a2c9bf3a41def797866bf47a2c95e0a441395031e759d981f
- document type
- citation
- dois
- 10.1016/j.ejca.2012.11.010
- electronic publication date
- display
- 2012 Dec 19
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23265714
- immutable id
- pubmed:23265714@1115fc3d454e973a2c9bf3a41def797866bf47a2c95e0a441395031e759d981f
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- 6
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 1346-55
- volume
- 49
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23265714
- provenance
- batch id
- 99e85dbb34a1a3011c9a
- provider
- NCBI PubMed ESummary
- record sha256
- e7533ee3a9b843cd44492b156ac61773566d574bf4bde5048ec528e385cc686b
- response sha256
- 1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
- retrieved at
- 2026-09-09T23:46:52.860383+00:00
- publication date
- display
- 2013 Apr
- precision
- month
- year
- 2013
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
Preserved source evidence · Not medical advice